Clovis Oncology, Inc. (CLVS): Price and Financial Metrics
Clovis Oncology, Inc. (CLVS)
Today's Latest Price: $8.39 USD
0.18 (-2.10%)
Updated Jan 28 6:55pm
Add CLVS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CLVS Stock Summary
- Clovis Oncology Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 4.22% of US listed stocks.
- CLVS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 99.19% of US stocks.
- The volatility of Clovis Oncology Inc's share price is greater than that of 95.88% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Clovis Oncology Inc, a group of peers worth examining would be ATNX, XPL, SQNS, FOLD, and CLSN.
- CLVS's SEC filings can be seen here. And to visit Clovis Oncology Inc's official web site, go to www.clovisoncology.com.
CLVS Daily Price Range
CLVS 52-Week Price Range
CLVS Stock Price Chart More Charts
CLVS Price/Volume Stats
| Current price | $8.39 | 52-week high | $32.05 |
| Prev. close | $8.57 | 52-week low | $2.93 |
| Day low | $8.27 | Volume | 3,438,700 |
| Day high | $8.78 | Avg. volume | 9,213,883 |
| 50-day MA | $10.24 | Dividend yield | N/A |
| 200-day MA | $10.33 | Market Cap | 459.90M |
Clovis Oncology, Inc. (CLVS) Company Bio
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. The company was founded in 2009 and is based in Boulder, Colorado.
Top Stories View All
3 Top Tech Stock Upgrades to Strong Buy
Best & Worst Performing Stock Industries for January 28, 2020
Best & Worst Performing Small Cap Stocks for January 28, 2020
Best & Worst Performing Mid Cap Stocks for January 28, 2020
Best & Worst Performing Large Cap Stocks for January 28, 2020
View All Top Stories
Loading social stream, please wait...